SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Shasun Pharmaceuticals informs about business updates

18 Nov 2015 Evaluate

With reference to the earlier letter dated November 17, 2015 regarding the fire accident in one of the manufacturing blocks of the Company’s Cuddalore API facility, Shasun Pharmaceuticals has now informed that the Company have temporarily suspended the production, as directed by the Government authorities. The Company is working with the Government authorities to resume operations at the earliest. The Company confirms that there will be no material impact on the revenue of the group during the current financial year.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×